Polymyalgia rheumatica and risk of coronary artery disease: a systematic review and meta-analysis of observational studies

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Several chronic inflammatory disorders, such as rheumatoid arthritis and systemic lupus erythematosus, are associated with an increased risk of coronary artery disease (CAD) as a result of accelerated atherosclerosis. However, the data on CAD risk of polymyalgia rheumatica (PMR), one of the most common chronic inflammatory disorders in older adults, remain unclear due to limited number of epidemiological studies. To further investigate this possible association, this systematic review and meta-analysis of observational studies was performed to compare the risk of CAD in patients with PMR versus subjects without it. Published studies indexed in MEDLINE and EMBASE were searched from inception to April 2016 using the terms “polymyalgia rheumatica” combined with the terms for CAD. The inclusion criteria were: (1) observational studies published as original studies to evaluate the risk of CAD among patients with PMR; (2) published odds ratios, relative risk or hazard ratio or standardized incidence ratio with 95 % confidence intervals (CI) in the studies; and (3) subjects without PMR were used as comparators in cohort studies and cross-sectional studies, while subjects without CAD were used as comparators in case–control studies. Point estimates and standard errors were extracted from individual studies and were combined by the generic inverse variance method of DerSimonian and Laird. Four studies with 34,569 patients with PMR were identified and included in this meta-analysis. The pooled risk ratio of CAD in patients with PMR was 1.72 (95 % CI 1.21–2.45). The statistical heterogeneity of this meta-analysis was high with an I2 of 97 %.

Original languageEnglish (US)
Pages (from-to)1-7
Number of pages7
JournalRheumatology International
DOIs
StateAccepted/In press - Aug 30 2016

Fingerprint

Polymyalgia Rheumatica
Observational Studies
Meta-Analysis
Coronary Artery Disease
Odds Ratio
Confidence Intervals
MEDLINE
Systemic Lupus Erythematosus
Epidemiologic Studies
Rheumatoid Arthritis
Atherosclerosis
Cohort Studies
Cross-Sectional Studies
Incidence

Keywords

  • Cardiovascular disease
  • Epidemiology
  • Meta-analysis
  • Polymyalgia rheumatica

ASJC Scopus subject areas

  • Immunology and Allergy
  • Rheumatology
  • Immunology

Cite this

@article{7e2d29d5053d405c97a8065ba7235034,
title = "Polymyalgia rheumatica and risk of coronary artery disease: a systematic review and meta-analysis of observational studies",
abstract = "Several chronic inflammatory disorders, such as rheumatoid arthritis and systemic lupus erythematosus, are associated with an increased risk of coronary artery disease (CAD) as a result of accelerated atherosclerosis. However, the data on CAD risk of polymyalgia rheumatica (PMR), one of the most common chronic inflammatory disorders in older adults, remain unclear due to limited number of epidemiological studies. To further investigate this possible association, this systematic review and meta-analysis of observational studies was performed to compare the risk of CAD in patients with PMR versus subjects without it. Published studies indexed in MEDLINE and EMBASE were searched from inception to April 2016 using the terms “polymyalgia rheumatica” combined with the terms for CAD. The inclusion criteria were: (1) observational studies published as original studies to evaluate the risk of CAD among patients with PMR; (2) published odds ratios, relative risk or hazard ratio or standardized incidence ratio with 95 {\%} confidence intervals (CI) in the studies; and (3) subjects without PMR were used as comparators in cohort studies and cross-sectional studies, while subjects without CAD were used as comparators in case–control studies. Point estimates and standard errors were extracted from individual studies and were combined by the generic inverse variance method of DerSimonian and Laird. Four studies with 34,569 patients with PMR were identified and included in this meta-analysis. The pooled risk ratio of CAD in patients with PMR was 1.72 (95 {\%} CI 1.21–2.45). The statistical heterogeneity of this meta-analysis was high with an I2 of 97 {\%}.",
keywords = "Cardiovascular disease, Epidemiology, Meta-analysis, Polymyalgia rheumatica",
author = "Patompong Ungprasert and Matthew Koster and Warrington, {Kenneth J} and Matteson, {Eric Lawrence}",
year = "2016",
month = "8",
day = "30",
doi = "10.1007/s00296-016-3557-5",
language = "English (US)",
pages = "1--7",
journal = "Rheumatology International",
issn = "0172-8172",
publisher = "Springer Verlag",

}

TY - JOUR

T1 - Polymyalgia rheumatica and risk of coronary artery disease

T2 - a systematic review and meta-analysis of observational studies

AU - Ungprasert, Patompong

AU - Koster, Matthew

AU - Warrington, Kenneth J

AU - Matteson, Eric Lawrence

PY - 2016/8/30

Y1 - 2016/8/30

N2 - Several chronic inflammatory disorders, such as rheumatoid arthritis and systemic lupus erythematosus, are associated with an increased risk of coronary artery disease (CAD) as a result of accelerated atherosclerosis. However, the data on CAD risk of polymyalgia rheumatica (PMR), one of the most common chronic inflammatory disorders in older adults, remain unclear due to limited number of epidemiological studies. To further investigate this possible association, this systematic review and meta-analysis of observational studies was performed to compare the risk of CAD in patients with PMR versus subjects without it. Published studies indexed in MEDLINE and EMBASE were searched from inception to April 2016 using the terms “polymyalgia rheumatica” combined with the terms for CAD. The inclusion criteria were: (1) observational studies published as original studies to evaluate the risk of CAD among patients with PMR; (2) published odds ratios, relative risk or hazard ratio or standardized incidence ratio with 95 % confidence intervals (CI) in the studies; and (3) subjects without PMR were used as comparators in cohort studies and cross-sectional studies, while subjects without CAD were used as comparators in case–control studies. Point estimates and standard errors were extracted from individual studies and were combined by the generic inverse variance method of DerSimonian and Laird. Four studies with 34,569 patients with PMR were identified and included in this meta-analysis. The pooled risk ratio of CAD in patients with PMR was 1.72 (95 % CI 1.21–2.45). The statistical heterogeneity of this meta-analysis was high with an I2 of 97 %.

AB - Several chronic inflammatory disorders, such as rheumatoid arthritis and systemic lupus erythematosus, are associated with an increased risk of coronary artery disease (CAD) as a result of accelerated atherosclerosis. However, the data on CAD risk of polymyalgia rheumatica (PMR), one of the most common chronic inflammatory disorders in older adults, remain unclear due to limited number of epidemiological studies. To further investigate this possible association, this systematic review and meta-analysis of observational studies was performed to compare the risk of CAD in patients with PMR versus subjects without it. Published studies indexed in MEDLINE and EMBASE were searched from inception to April 2016 using the terms “polymyalgia rheumatica” combined with the terms for CAD. The inclusion criteria were: (1) observational studies published as original studies to evaluate the risk of CAD among patients with PMR; (2) published odds ratios, relative risk or hazard ratio or standardized incidence ratio with 95 % confidence intervals (CI) in the studies; and (3) subjects without PMR were used as comparators in cohort studies and cross-sectional studies, while subjects without CAD were used as comparators in case–control studies. Point estimates and standard errors were extracted from individual studies and were combined by the generic inverse variance method of DerSimonian and Laird. Four studies with 34,569 patients with PMR were identified and included in this meta-analysis. The pooled risk ratio of CAD in patients with PMR was 1.72 (95 % CI 1.21–2.45). The statistical heterogeneity of this meta-analysis was high with an I2 of 97 %.

KW - Cardiovascular disease

KW - Epidemiology

KW - Meta-analysis

KW - Polymyalgia rheumatica

UR - http://www.scopus.com/inward/record.url?scp=84984799258&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84984799258&partnerID=8YFLogxK

U2 - 10.1007/s00296-016-3557-5

DO - 10.1007/s00296-016-3557-5

M3 - Article

C2 - 27577940

AN - SCOPUS:84984799258

SP - 1

EP - 7

JO - Rheumatology International

JF - Rheumatology International

SN - 0172-8172

ER -